PDSB
PDS Biotechnology Corp
0.7971$
-0.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +5.0% | +0.0% | 0.0% | +0.0% | +0.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +15.8% | -10.2% | -32.5% | +50.3% | -33.4% | +28.7% | -27.7% | +8.6% | -3.7% | -21.5% | -5.5% | – | |
| – | -34.2% | +26.8% | +22.5% | -18.8% | -16.1% | +15.7% | +4.1% | +4.5% | -36.3% | +134,928.9% | -99.9% | – | |
| – | -1.1% | -3.0% | -14.0% | +17.2% | -27.8% | +24.0% | -16.3% | +6.8% | -18.0% | -2.3% | -0.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +9.9% | +0.0% | +1.1% | +2.3% | -9.8% | -15.1% | +130.4% | -46.4% | -3.3% | -8.8% | +233.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +150.0% | -17,383,480.0% | – | – | -100.1% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.